PR, Media News, Client Updates & Observations from Absolutely PR in Denver

_______________________________________________

Follow on Twitter (since June 2008): www.twitter.com/DenverPR
Read Client Pitches & Placements (since July 2005): http://denverpr.blogspot.com
Checkout Denver PR Newsroom (since March 2002): www.DenverPRNewsroom.com

HOMECONTACTLeadershipBrand ExperienceNewsSocial/Digital MediaE-PortfolioResultsOnline ExposureWhy PR?How PR?News HooksBlog - UpdatesIRPR.US

Wednesday, October 8, 2014

InnovatioNews: 'CID4 awards $200K to Sapphire Technology to advance development of dental instruments'
Quoting from today's posting:

"The Colorado Institute for Drug, Device and Diagnostic Development (CID4) awarded $200,000 to Denver-based Sapphire Technology LLC to develop the company’s proprietary dental instruments.

Sapphire is a development-stage dental device company advancing proprietary sapphire-tipped instruments for use in dental procedures involving photo-cured, resin composite filling and restoration materials.

'We are extremely excited about our investment and involvement in Sapphire Technology,' said Kevin Smith, CID4 president and CEO."
 
Link to InnovatioNews
5:39 pm edt          Comments

Denver Post: 'Denver-based Sapphire Technology gets funding for gemstone-tipped dental instruments'
Quoting from yesterday's posting by Laura Keeney:

"Your dental visit may soon have a lot more bling.

Denver-based Sapphire Technology LLC on Tuesday was awarded $200,000 from the Colorado Institute for Drug, Device and Diagnostic Development, or CID4, for continued development of its dental instruments made with sapphires.

Sapphire, which is a gemstone variety of corundum, ranks at the top of the Mohs scale of mineral hardness — the universal standard to measure the hardness of gemstones and minerals.

The gemstone has been in the news recently amid speculation that Apple might use highly scratch-resistant glass made of sapphires for its new iPhone screens.

But what does this have to do with dental work?"
 
Link to the Denver Post
5:33 pm edt          Comments

Wednesday, September 17, 2014

Four Colorado Bioscience Companies Present at the Inaugural White Hat Life Science Investor Conference in Phoenix
 
Colorado BioScience Association (CBSA) congratulates the four Colorado headquartered companies selected to present at the inaugural White Hat Life Science Investor Conference being held September 17 and 18 at the Grand Hyatt in Phoenix, AZ. The announcement is made by April Giles, CBSA President and CEO, who says, “We’re excited to be a partner in the 2014 White Hat Life Science Investor Conference and to help showcase three of Colorado’s promising bioscience companies during the event.” The participating Colorado companies include EndoShape, Fluonic, ValveXchange and ViroCyt.

The conference, spearheaded by the Arizona BioIndustry Association (AZBio), is presented by the National Venture Capital Association and leading life science associations of the Rocky Mountain Southwest Region, including the CBSA. This conference is showcasing 34 of the region’s top life science companies to interested investors including business development professionals from large pharmaceutical, biotechnology, medical device and diagnostic companies.

“The Rocky Mountain and Southwest Regions have become increasingly recognized for their growth in the bioscience and heath care innovations. The White Hat Life Science Investor Conference will act as another opportunity to highlight the work being done in Colorado and the surrounding region while at the same time bringing new potential partners and investors into our community,” Giles said. 

Colorado bioscience companies selected to present in the 2014 White Hat Investor Conference:

EndoShape, Inc., Boulder – EndoShape’s mission is to commercialize novel medical devices based on its proprietary polymer technology. EndoShape is focused on the coil embolization and occlusion market. EndoShape is currently commercializing the Medusa™ Vascular Plug which is FDA 510(k) cleared for sale in the United States. Visit, http://www.endoshape.com.

Fluonic, Inc., Boulder - Fluonic is a privately held medical device company dedicated to making infusion drug delivery safer for patients through the development of a new generation of infusion devices and information systems, driven by a breakthrough MEMS flow sensor technology. Fluonic infusion products improve patients’ safety and compliance while improving medical staff productivity and reducing costs, which will set a new standard of care for the industry. Visit,http://fluonic.com.

* ValveXchange, Inc. – Greenwood Village – ValveXchange (VXi) is dedicated to improving the lives of patients requiring heart valve replacements. VXi is developing a two-piece bioprosthetic tissue valve system that resolves the long standing compromises between conventional mechanical and tissue-based prosthetic valves. Unlike today’s transcatheter valves, the VXi technology is Without Compromise. The VXi exchangeable valve system is being designed to offer leaflet exchange, as well as the original implant, without open-heart surgery and without the safety and longevity compromises of transcatheter approaches. Visit: http://www.valvexchange.com.

ViroCyt, LLC, Boulder - ViroCyt, LLC was created in late 2012 to focus on the commercialization of novel technologies that enable rapid quantification of viruses, such as the Virus Counter® 3100. The Company’s mission is to provide the tools that deliver meaningful improvements to critical biotechnology processes such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role. Visit, http://www.virocyt.com.

For more information and a complete listing of presenting companies, visit the conference website at http://www.azbio.org/white-hat-investors-2014

Link to the related PitchEngine Social Media Release
3:25 pm edt          Comments

Tuesday, September 16, 2014

Video Highlights: BioWest 2014, Marriott City Center, Denver
BioWest 2014 Video Highlights

Founders Breakfast Health and Wellness Panel: Introductions BySteve VanNurden -http://youtu.be/23faLOw30ac

Health/Wellness Panel: Jandel Allen-Davis on the Kaiser Model -http://youtu.be/qzUO1_QayvI 

Health/Wellness Panel: James Hill on Extreme Weight Loss TV - http://youtu.be/p2xukgmHKRI

Health/Wellness Panel: Len Tacconi on What Works -http://youtu.be/dL3ddy08DPA 

C-Level Unplugged: Larry Gold, Chairman of the Board, SomaLogic -http://youtu.be/j8EiWcLkkzQ 
C-Level Unplugged: Shar Matin, COO, Spectranetics - http://youtu.be/BIxzpNwmI_0 
CEO Panel: Bill Aldrich, CEO, EndoShape -http://youtu.be/T-mLI0GM7mo

CEO Panel: David Brunel, CEO, Biodesix -http://youtu.be/hRaO0zao-yc

CEO Panel: Byron Hewett, CEO, SomaLogic - http://youtu.be/W501l9z6FEo 


BioTalks Excerpt:Jonathan Norris – Investments, Exits - http://youtu.be/8s3pjDmqscU

BioTalks Excerpt: David Gary, Clinical Trials Ethics - http://youtu.be/7g6V7082kr0

BioTalks Excerpt: Iya Khalil on Big Data Healthcare - http://youtu.be/QFuad4jPIEE

BioTalks Excerpt: Robert Atkinson, How Colorado Ranks -http://youtu.be/AJ8mYHWm-o8

BioTalks Excerpt: Rhea May, Superbugs - http://youtu.be/fGon5MgE6qs

BioTalks Excerpt: Larry Blankenship, Valley of Death -http://youtu.be/ZgfeTYvNxw0

BioTalks Excerpt: Mark Sirangelo, Innovation in Colorado -http://youtu.be/iUhM1WL3DeQ

BioTalks Excerpt: Lindsay Guerdrum, Beer Bioscience -http://youtu.be/YWuXZ1AmWzM 


Russell Slifer – About the USPTO -http://youtu.be/T8Up-0LcwAY

Russell Slifer – USPTO Rocky Mtn Regional Office -http://youtu.be/WlgkRDM0Ue0 
Venture Showcase Sponsors and Judgeshttp://youtu.be/N2MwTev0rLk

dBMEDx Winning Venture Showcase Presentation -http://youtu.be/TUoQK71wPEU

KromaTiD Venture Showcase Presentation - http://youtu.be/QHnrLHNo3D8

Mighty Oak Medical Venture Showcase Presentation -http://youtu.be/r9oYdewEbvk 

FDA Commissioner Hamburg Opening Remarks to Closing Keynote -http://youtu.be/3Wkqls_9zuw

Link to the related InnovatioNews article

Link to the related Denver Post article

Link to the related Denver Business Journal article
4:20 pm edt          Comments

Colorado Med Device Company dBMEDx Wins the Venture Showcase Competition at BioWest 2014
dBMEDx (Littleton)won the 2014 Venture Showcase competition at the BioWest Conference and Expo yesterday at the Marriott City Center Denver, receiving the $7,500 cash prize. The announcement is made by April Giles, Colorado BioScience Association (CBSA) President and CEO who says, “We are very proud to announce dBMEDx as the winner of the Venture Showcase. The check presentation was an exciting end to the BioWest Conference. The award not only includes the cash prize of $7,500 but also includes recognition and exposure for the company. ” This award is sponsored by Dorsey and Whitney LLP and The Metro Denver Economic Development Corporation. BioWest, the Rocky Mountain Region's premier medical device and biotechnology conference, is organized by the CBSA and held every other year. 

dBMEDx is a Colorado-based medical device development company that is creating clinical decision and patient monitoring devices using its patented, non-invasive scanning technology. These devices combine the power and safety of ultrasound with sophisticated image processing electronics and software to provide simple, fully automated and completely noninvasive diagnostic measurements.  Fully automated means that very little training is required and the user does not need any experience with ultrasound to use our devices. To enable this level of automation, dBMEDx has successfully created and patented an extremely compact, wireless, 3D scan engine.

The scan engine, which can be held in the palm of the hand, includes a complete 3D ultrasound imaging machine and automated image processor within a small, sealed tube.  The system also includes an integrated Bluetooth radio and rechargeable battery, which is inductively charged. The company is in the process of commercializing the first application for this technology, the BBS Revolution™ device for automated bladder volume measurement, and has a range of pipeline of products for other clinical applications as well. Visit: http://www.dbmedx.com.

Video of winning Venture Showcase pitch by dBMEDx CEO David Shine:

 
http://youtu.be/TUoQK71wPEU 

The Venture Showcase format allowed each company’s lead executive to make a 15-minute presentation with an accompanying slide deck explaining their technology and business plan to a panel of judges in front of a live audience. This year's judging panel included the following:

• Michael Weiner, Partner, Dorsey
• Ned Scheetz, Managing Director, Aphelion Capital
• Steve VanNurden, President and CEO, Fitzsimons Redevelopment Authority

The three 2014 Venture Showcase finalists included:

dBMEDx – Littleton http://www.dbmedx.com
KromaTiD, Inc. - Fort Collinshttp://www.kromatid.com
Mighty Oak Medical – Englewoodhttp://www.mightyoakmedical.com

The BioWest Conference was attended by more than 300 industry leaders, government representatives, executives, researchers, investors and entrepreneurs. “We look forward to the continued growth of the bioscience industry and presenting the conference in again 2016,” Giles concludes.

Link to the related Business Wire

Link to the PitchEngine Social Media Release 
2:04 pm edt          Comments

2014.10.01 | 2014.09.01 | 2014.07.01 | 2014.06.01 | 2014.05.01 | 2014.04.01 | 2014.03.01 | 2013.09.01 | 2013.08.01 | 2012.12.01 | 2012.09.01 | 2012.07.01 | 2012.06.01 | 2012.03.01 | 2012.02.01 | 2011.12.01 | 2011.11.01 | 2011.10.01 | 2011.09.01 | 2011.06.01 | 2011.05.01 | 2010.12.01 | 2010.09.01 | 2010.08.01 | 2010.07.01 | 2010.05.01 | 2010.04.01 | 2010.03.01 | 2010.02.01 | 2010.01.01

Link to web log's RSS file

The Absolutely PR Blog is listed on Blog Catalog:

http://www.blogcatalog.com/blogs/absolutely-pr-blog.html